Brainstorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson’s Disease. The Company's platform technology, NurOwn®, uses proprietary culture conditions to induce mesenchymal stem cells to secrete high levels of neurotrophic factors known to promote the survival of neurons. NurOwn® cells dampen the immune system and secrete growth factors that help damaged neurons survive.